Heart failure and sepsis: practical recommendations for the optimal management

[1]  Tommaso Piani,et al.  Accuracy of Ultrasonographic Measurements of Inferior Vena Cava to Determine Fluid Responsiveness: A Systematic Review and Meta-Analysis , 2020, Journal of intensive care medicine.

[2]  Pengfei Guo,et al.  A meta-analysis of randomized controlled trials , 2019, Medicine.

[3]  M. Kearney,et al.  Prevalence and Predictors of Sepsis Death in Patients With Chronic Heart Failure and Reduced Left Ventricular Ejection Fraction , 2018, Journal of the American Heart Association.

[4]  R. Bellomo,et al.  Correction to: Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients , 2018, Intensive Care Medicine.

[5]  A. Mebazaa,et al.  Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction. , 2018, Journal of the American College of Cardiology.

[6]  R. Bellomo,et al.  Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients , 2018, Intensive Care Medicine.

[7]  M. Levy,et al.  The Surviving Sepsis Campaign Bundle: 2018 Update. , 2018, Critical care medicine.

[8]  T. Coats,et al.  Fluid therapy in the emergency department: an expert practice review , 2018, Emergency Medicine Journal.

[9]  A. Mebazaa,et al.  Acute Heart Failure Management , 2018, Korean circulation journal.

[10]  Mitchell M. Levy,et al.  The Surviving Sepsis Campaign Bundle: 2018 update , 2018, Intensive Care Medicine.

[11]  Jesse M. Ehrenfeld,et al.  Balanced Crystalloids versus Saline in Critically Ill Adults , 2018, Journal Club AINS.

[12]  F. V. Haren.  Personalised fluid resuscitation in the ICU: still a fluid concept? , 2017 .

[13]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[14]  J. Stowell,et al.  154 Fluid Resuscitation of Septic Patients at Risk for Fluid Overload , 2017 .

[15]  Yaqing Ma,et al.  Efficacy and safety of levosimendan in patients with acute right heart failure: A meta‐analysis , 2017, Life sciences.

[16]  S. Keenan,et al.  Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure , 2017, European Respiratory Journal.

[17]  V. Noble,et al.  International Federation for Emergency Medicine Consensus Statement: Sonography in hypotension and cardiac arrest (SHoC): An international consensus on the use of point of care ultrasound for undifferentiated hypotension and during cardiac arrest. , 2017, CJEM.

[18]  P. Ponikowski,et al.  Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX‐AHF‐2 study , 2017, European journal of heart failure.

[19]  P. Ponikowski,et al.  Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure , 2017, The New England journal of medicine.

[20]  Alan E. Jones,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 , 2017, Intensive Care Medicine.

[21]  Sangeeta Mehta,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 , 2017, Intensive Care Medicine.

[22]  A. Malhotra,et al.  1482: IMPACT OF FLUID RESUSCITATION ON SEPTIC PATIENTS WITH SYSTOLIC HEART FAILURE , 2016, Critical care medicine.

[23]  Gavin D Perkins,et al.  Levosimendan for the Prevention of Acute Organ Dysfunction in Sepsis. , 2016, The New England journal of medicine.

[24]  R. Sato,et al.  Prevalence and risk factors of sepsis-induced cardiomyopathy , 2016, Medicine.

[25]  G. Hassen,et al.  The Effect of Initial Volume Resuscitation for Sepsis in Patients with Congestive Heart Failure: Is it Associated with Higher Mortality , 2016 .

[26]  Volkmar Falk,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.

[27]  Dongyin Zhang,et al.  Simvastatin ameliorates ventricular remodeling via the TGF-β1 signaling pathway in rats following myocardial infarction , 2016, Molecular medicine reports.

[28]  M. Singer,et al.  Heart rate reduction with esmolol is associated with improved arterial elastance in patients with septic shock: a prospective observational study , 2016, Intensive Care Medicine.

[29]  Takashi Ito,et al.  Sepsis-induced myocardial dysfunction: pathophysiology and management , 2016, Journal of Intensive Care.

[30]  K. Sliwa,et al.  Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance , 2016, Intensive Care Medicine.

[31]  G. Filippatos,et al.  Current state of knowledge on Takotsubo syndrome: a Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology , 2016, European journal of heart failure.

[32]  A. Zangrillo,et al.  Levosimendan reduces mortality in patients with severe sepsis and septic shock: A meta-analysis of randomized trials. , 2015, Journal of critical care.

[33]  S. Gopal,et al.  Systematic review of use of β-blockers in sepsis , 2015, Journal of anaesthesiology, clinical pharmacology.

[34]  F. Sanfilippo,et al.  Beta-blocker use in severe sepsis and septic shock: a systematic review , 2015, Current medical research and opinion.

[35]  J. Zijlstra,et al.  Glucocorticosteroids for sepsis: systematic review with meta-analysis and trial sequential analysis , 2015, Intensive Care Medicine.

[36]  A. Mebazaa,et al.  Clevidipine in acute heart failure: Results of the A Study of Blood Pressure Control in Acute Heart Failure-A Pilot Study (PRONTO). , 2014, American heart journal.

[37]  A. Zangrillo,et al.  The Effect of Statins on Mortality in Septic Patients: A Meta-Analysis of Randomized Controlled Trials , 2013, PloS one.

[38]  S. Scolletta,et al.  Clinical management of the cardiovascular failure in sepsis. , 2013, Current vascular pharmacology.

[39]  C. Sprung,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock 2012 , 2013, Critical care medicine.

[40]  Piotr Ponikowski,et al.  Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial , 2013, The Lancet.

[41]  R. Branson,et al.  Pre-Hospital Oxygen Therapy , 2013, Respiratory Care.

[42]  P. Perera,et al.  Caval Sonography in Shock , 2012, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[43]  V. Herasevich,et al.  Clinical spectrum, frequency, and significance of myocardial dysfunction in severe sepsis and septic shock. , 2012, Mayo Clinic proceedings.

[44]  D. Annane,et al.  Effects of esmolol on systemic and pulmonary hemodynamics and on oxygenation in pigs with hypodynamic endotoxin shock , 2011, Intensive Care Medicine.

[45]  Adrian F Hernandez,et al.  Diuretic strategies in patients with acute decompensated heart failure. , 2011, The New England journal of medicine.

[46]  A. Delaney,et al.  The role of albumin as a resuscitation fluid for patients with sepsis: A systematic review and meta-analysis* , 2011, Critical care medicine.

[47]  M. Etminan,et al.  The effect of statins on mortality from severe infections and sepsis: a systematic review and meta-analysis. , 2010, Journal of critical care.

[48]  Colleen B Kjelland,et al.  The Role of Serum Lactate in the Acute Care Setting , 2010, Journal of intensive care medicine.

[49]  J. McMurray,et al.  Potentially detrimental cardiovascular effects of oxygen in patients with chronic left ventricular systolic dysfunction , 2010, Heart.

[50]  G. Fonarow,et al.  Early vasoactive drugs improve heart failure outcomes. , 2009, Congestive heart failure.

[51]  H. Iwasaka,et al.  LANDIOLOL, AN ULTRASHORT-ACTING &bgr;1-ADRENOCEPTOR ANTAGONIST, HAS PROTECTIVE EFFECTS IN AN LPS-INDUCED SYSTEMIC INFLAMMATION MODEL , 2009, Shock.

[52]  J. Rouby,et al.  Acute left ventricular dilatation and shock-induced myocardial dysfunction* , 2009, Critical care medicine.

[53]  H. Ulmer,et al.  Combined milrinone and enteral metoprolol therapy in patients with septic myocardial depression , 2008, Critical care.

[54]  Therapy Study Investigators,et al.  A comparison of epinephrine and norepinephrine in critically ill patients , 2008, Intensive Care Medicine.

[55]  Brian H Cuthbertson,et al.  Hydrocortisone therapy for patients with septic shock. , 2008, The New England journal of medicine.

[56]  E. Vicaut,et al.  A randomized study of out-of-hospital continuous positive airway pressure for acute cardiogenic pulmonary oedema: physiological and clinical effects. , 2007, European heart journal.

[57]  M. Singer.  Catecholamine treatment for shock—equally good or bad? , 2007, The Lancet.

[58]  M. Merx,et al.  Statins in the intensive care unit , 2006, Current opinion in critical care.

[59]  M. Singer,et al.  Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression , 2006, Intensive Care Medicine.

[60]  J. Takeda,et al.  Infusion of the &bgr;-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats* , 2005, Critical care medicine.

[61]  D. Carlson,et al.  Tumor necrosis factor-α-induced caspase activation mediates endotoxin-related cardiac dysfunction* , 2005, Critical care medicine.

[62]  Djillali Annane,et al.  Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis , 2004, BMJ : British Medical Journal.

[63]  Robyn Norton,et al.  A comparison of albumin and saline for fluid resuscitation in the Intensive Care unit , 2005 .

[64]  A. Torres,et al.  Noninvasive ventilation in severe hypoxemic respiratory failure: a randomized clinical trial. , 2003, American journal of respiratory and critical care medicine.

[65]  N. Hill,et al.  Acute applications of noninvasive positive pressure ventilation. , 2003, Chest.

[66]  D. Annane,et al.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. , 2002, JAMA.

[67]  E. Ivers,et al.  Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock , 2001 .

[68]  Joerg Kallen,et al.  Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site , 2001, Nature Medicine.

[69]  M. Antonelli,et al.  A Comparison of Noninvasive Positive-Pressure Ventilation and Conventional Mechanical Ventilation in Patients with Acute Respiratory Failure , 1998 .

[70]  P. Bollaert,et al.  Reversal of late septic shock with supraphysiologic doses of hydrocortisone. , 1998, Critical care medicine.

[71]  Y. Moshkovitz,et al.  Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema , 1998, The Lancet.

[72]  S. Lawless,et al.  Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study. , 1996, Chest.

[73]  J. Shelhamer,et al.  Profound but reversible myocardial depression in patients with septic shock. , 1984, Annals of internal medicine.

[74]  J. Rawles,et al.  Controlled trial of oxygen in uncomplicated myocardial infarction. , 1976, British medical journal.

[75]  Jesse M. Ehrenfeld,et al.  Balanced Crystalloids versus Saline in Noncritically Ill Adults , 2018, The New England journal of medicine.